Expression of DCUN1D1 in laryngeal squamous cell carcinoma and its inhibiting effect on TU-177 cells after interfered by RNA.

Authors:
Jing Liu
Jing Liu
MOE Key Laboratory of Environmental Remediation and Ecosystem Health
China
Yu Shuang
Yu Shuang
the Second Affiliated Hospital of Tianjin Medical University
China
Chao Li
Chao Li
School of Food Science and Engineering
United States
Xuan Zhou
Xuan Zhou
College of Veterinary Medicine
China
Yongwang Huang
Yongwang Huang
Second Hospital of Tianjin Medical University
Lun Zhang
Lun Zhang
Chengdu University of Traditional Chinese Medicine
China

Clin Exp Pharmacol Physiol 2018 May 21;45(5):461-466. Epub 2017 Dec 21.

Department of Otorhinolaryngology and Maxillofacial Oncology, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Cancer Institute, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.

Expression of DCUN1D1 in laryngeal squamous cell carcinoma (LSCC) and its inhibition by small interfering RNA (siRNA) target in the TU-177 cells was investigated. Immunohistochemistry was used to detect the expression level of DCUN1D1 in LSCC tissue in 140 cases and to analyze its relationship with clinical pathological characteristics. siRNA expression plasmid targeting DCUN1D1 was constructed and transferred into TU-177 cells. The effect of siRNA target DCUN1D1 gene silencing on proliferation, invasion and migration of TU-177 cells were observed by MTS assay and Transwell experiment. The expression levels of focal adhesion kinase (FAK) and matrix metalloproteinase-2(MMP-2) were detected by western blot. Expression level of DCUN1D1 protein increased significantly in T3 + T4, N+, and III + IV stages of LSCC patients (P < .05). After DCUN1D1 was targeted by siRNA, the DCUN1D1 protein level decreased 67% in siRNA-3 group, where average absorbance value was lower than the control and blank group with significant difference(F = 6.076, P < .05) in MTS assay, meantime migration, and invasion cells in each vision were the same (F = 19.851, F = 25.454, P < .01) in the Transwell experiment. The expression level of FAK and MMP-2 was significantly down-regulated in siRNA-3 group (F = 28.896, F = 40.240, P < .01). DCUN1D1 is associated with progression and prognosis of LSCC. After siRNA based target on DCUN1D1, TU-177 cells growth was inhibited and invasion of malignant tumour was diminished by reducing the expression of FAK and MMP-2. DCUN1D1 is could become a potential new target for the treatment of LSCC.

Download full-text PDF

Source
http://dx.doi.org/10.1111/1440-1681.12893DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
May 2018
11 Reads

Publication Analysis

Top Keywords

tu-177 cells
16
cell carcinoma
8
sirna target
8
level dcun1d1
8
squamous cell
8
expression level
8
expression dcun1d1
8
laryngeal squamous
8
dcun1d1 laryngeal
8
expression
6
dcun1d1
5
blot expression
4
clinical pathological
4
pathological characteristics
4
sirna expression
4
expression plasmid
4
western blot
4
adhesion kinase
4
characteristics sirna
4
dcun1d1 protein
4

Similar Publications